Supriya Lifescience Limited
NSE:SUPRIYA.NS
609.25 (INR) • At close September 19, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) INR.
| 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||||||
| Nettowinst
| 369.32 | 297.87 | 238.84 | 285.11 | 382.29 | 95.18 | 168.62 | 252.49 | 462.11 | 396.4 | 582.2 | 77.39 | 474.07 | 156.93 |
| Afschrijvingen & Amortisatie
| 0 | 39.6 | 39.81 | 39.55 | 30.07 | 29.5 | 29.73 | 0 | 0 | 0 | 0 | 0 | 16.62 | 0 |
| Uitgestelde Inkomstenbelasting
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verandering in Werkkapitaal
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -262.45 | 0 |
| Vorderingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -192.56 | 0 |
| Voorraden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -107.8 | 0 |
| Crediteuren
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overig Werkkapitaal
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37.91 | 0 |
| Overige Niet-Contante Posten
| -369.32 | -297.87 | -238.84 | -285.11 | -382.29 | -95.18 | -168.62 | -252.49 | -462.11 | -396.4 | -582.2 | -77.39 | 146.01 | -156.93 |
| Kasstroom uit Operationele Activiteiten
| 0 | 79.2 | 79.62 | 79.1 | 60.14 | 59 | 59.46 | 0 | 0 | 0 | 0 | 0 | 374.25 | 0 |
| Investeringsactiviteiten: | ||||||||||||||
| Investeringen in Materiële Vaste Activa
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -216.37 | 0 |
| Netto Overnames
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Investeringsactiviteiten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14.4 | 0 |
| Kasstroom uit Investeringsactiviteiten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -201.97 | 0 |
| Financieringsactiviteiten: | ||||||||||||||
| Schuldaflossingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.38 | 0 |
| Uitgifte van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -39.56 | 0 |
| Overige Financieringsactiviteiten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 123.99 | 0 |
| Kasstroom uit Financieringsactiviteiten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 87.81 | 0 |
| Overige Informatie: | ||||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 632.68 | 0 |
| Netto Kasstroomverandering
| 0 | 79.2 | 79.62 | 79.1 | 60.14 | 59 | 59.46 | 0 | 0 | 0 | 0 | 0 | 892.77 | 0 |
| Kaspositie aan het Einde van de Periode
| 0 | 1,119.61 | 1,040.41 | 852.81 | 773.71 | 1,954.69 | 1,895.69 | 0 | 0 | 0 | 0 | 892.77 | 892.77 | 0 |